Related Experiment Videos
Lessons learned from recent lipid-lowering trials: why physicians should change clinical practice
Karol E Watson1, Gregg C Fonarow
1Preventive Cardiology Program, Center for Lipid and Hypertension Management, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. kwatson@mednet.ucla.edu
Clinical Cornerstone
|January 1, 2004
Summary
Cholesterol reduction therapy benefits patients with average cholesterol levels, reducing cardiovascular disease (CVD) risk. Recent studies confirm its role in preventing and treating CVD events.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Preventive Cardiology
Background:
- Extensive data highlights cholesterol reduction's importance in cardiovascular disease (CVD) prevention and treatment.
- Previous trials focused on very high cholesterol; recent studies include average cholesterol levels.
Purpose of the Study:
- To evaluate the benefits of cholesterol reduction therapy in patients with average cholesterol levels.
- To synthesize evidence on cholesterol reduction for cardiovascular risk management.
Main Methods:
- Review of recent clinical trials, including the Heart Protection Study.
- Analysis of data on cholesterol levels and cardiovascular event rates.
Main Results:
- Evidence supports cholesterol reduction therapy for individuals with average cholesterol levels.
- Therapy effectively reduces the risk of cardiovascular events.
Conclusions:
- Cholesterol reduction is crucial for both prevention and treatment of CVD.
- Average cholesterol levels may also warrant therapeutic intervention for CVD risk reduction.